[Skip to the guide](#main) [Peptide Treatment Clinic](/) The usual paths into treatment, traced one by one. No bookings taken. [Home](/) [First checks](/first-check) [Questions](/ask-a-clinician) [Costs](/cost-checklist) Menu [Home](/) [First checks](/first-check) [Questions](/ask-a-clinician) [Costs](/cost-checklist) On this page [Visit preparation](#ask-prepare) [Question list](#ask-list) [Common questions](#ask-answers) [Urgent help](#ask-help) # Questions for a real conversation Bring the concern that sent you searching, along with the treatment name you found. Have the clinician put each answer into everyday words. A decision can wait while an answer is still unclear. [Read the questions](#ask-list) ## What to bring to the visit Describe the change you want and any steps you have taken so far. Add the medicines and supplements you use, the care you already receive, and anything you want the clinician to take into account. Circle the questions that matter most to you. Leave space for the answer. If the explanation introduces a new term, ask what it means before moving to the next point. You do not have to learn a new medical vocabulary to describe your own concern. ## Questions to keep beside you ### What problem does the plan address? Have the clinician name the problem being assessed and the purpose of the proposed care. How would you both judge progress? Which findings might call for another approach? Ask how that goal relates to the concern you brought, rather than just to the medicine name. ### Why this medicine rather than another option? Ask for the exact name and form of the proposed product. Ask what evidence supports using it for your situation and where that evidence falls short. Include the option of no medicine in the discussion. An answer needs to cover doubts and gaps, as well as the benefit being sought. When a pharmacist or doctor prepares medicine to order, that is compounding. An advertisement that presents a made-to-order medicine as identical to an approved drug is misleading, says the Food and Drug Administration (FDA). The agency gives the same warning about promises of proven equal results in [advertising guidance](https://www.fda.gov/drugs/human-drug-compounding/fda-telehealth-companies-what-know-when-promoting-compounded-drugs) checked in September 2026. ### Who makes and sends the medicine? FDA’s [compounding Q&A](https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers) notes that the person seeking care may not know the actual medicine maker’s name. Ask for the pharmacy’s name before a shipment is arranged. [FDA’s pharmacy lookup](https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy) leads to state license records. A listing shows the pharmacy has a license; it does not prove that the pharmacy fills and supplies each prescription properly. Keep that check separate from the clinician’s record. ### What needs checking before a decision? The [Federation of State Medical Boards (FSMB)](https://www.fsmb.org/siteassets/advocacy/policies/fsmb-workgroup-on-telemedicineapril-2022-final.pdf) sets out a process for needed testing. The guidance says a doctor must either carry out the test needed for your assessment, arrange testing elsewhere, or refer you for it. Ask what the proposed test would answer and what decision the result would inform. Ask which decisions must wait for the result and who will review it with you. If you are pregnant, nursing, or planning a pregnancy, put that question into the conversation before discussing a treatment choice. Ask for the information for the exact product being proposed. ### What problems could occur, and who would help? Ask what could go wrong, how to contact someone after the visit, and which problems call for urgent care. Request clear written instructions for the product if one is prescribed. Ask the clinician to work through anything that is unclear; do not use a general web page to fill in a missing instruction. ### How would follow-up work? Ask who would review progress, how to reach that person, and what could prompt a change or an end to treatment. If care begins online, ask where an in-person assessment would happen if needed. Include the cost of later visits and any testing in this conversation. ## Answers that help you judge the visit ### Can an online visit include a real assessment? [Medical-board policy](https://www.fsmb.org/siteassets/advocacy/policies/fsmb-workgroup-on-telemedicineapril-2022-final.pdf), checked in September 2026, permits a live call or online messages the doctor reads later, if the visit provides proper medical care for your problem. Under this policy, the doctor needs enough information to assess you and a way to ask for more details when needed. This policy advises state medical boards; the rules a doctor must obey are set by each state and differ across states, as of September 2026. Ask the medical board where you will be during the visit which rules apply there. Ask who reviews your replies and how you can raise a new question. ### Is choosing a treatment from a menu enough? The FSMB’s May 2026 [prescribing report](https://www.fsmb.org/siteassets/advocacy/policies/guidance-on-recent-trends-in-prescribing-and-dispensing-adopted.pdf) says a menu choice cannot stand in for an assessment of your medical problem. That report expects the prescriber to assess you as carefully as during an in-person visit. The same guidance calls for a way to ask follow-up questions. A menu is a prompt for discussion, rather than the assessment itself. ### Does “FDA registered” mean the treatment is approved? The September 2026 [registration rule](https://www.ecfr.gov/current/title-21/section-207.77) says a drug listing or facility registration grants no approval. It grants no right to market a product either. Ask for the exact product’s approval status instead of relying on the registration phrase. ## When to get urgent help [MedlinePlus describes anaphylaxis](https://medlineplus.gov/ency/article/000844.htm), a severe allergic reaction, as an emergency that can develop within seconds or minutes. For a severe reaction, MedlinePlus directs a call to 911; examples include a swollen tongue or difficulty breathing. [FDA’s MedWatch program](https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program) also accepts reports of medicine problems from people receiving care. Reporting a problem is separate from getting care for it. Keep the clinician’s contact route with the written plan. [Ask what the full plan costs](/cost-checklist) [Peptide Treatment Clinic](/) This reading guide traces routes into care, without operating a clinic or selling medicine. © Peptide Treatment Clinic [Home](/) [First checks](/first-check) [Questions](/ask-a-clinician) [Costs](/cost-checklist)